Protein Tyrosine Phosphatase 1B (PTP1B) in the immune system [PDF]
Journal not available online when checked 02/04/19.
Delibegovic, Mirela +3 more
core
Aim. To assess the efficacy profiles of different dosing regimens of tofacitinib, baricitinib, and upadacitinib — novel selective oral Janus activated kinase inhibitors, in rheumatoid arthritis (RA). Materials and methods.
A. E. Cheberda, D. Yu. Belousov
doaj +1 more source
This case report describes, to our knowledge, the first known successful treatment of airborne allergic contact dermatitis to sesquiterpene lactone with upadacitinib in an adult patient.
Barbara Marzario +2 more
doaj +1 more source
Advancing therapeutic frontiers: a pipeline of novel drugs for UC management
Ulcerative colitis is a chronic inflammatory bowel disease with rising global prevalence. Despite therapeutic advances including biologic agents targeting tumor necrosis factor-alpha, integrins, and interleukin pathways, alongside Janus kinase inhibitors
Luisa Bertin +9 more
doaj +1 more source
The role of Janus kinase signaling in graft-versus-host disease and graft versus leukemia [PDF]
Choi, Jaebok +3 more
core +2 more sources
Narrow spectrum kinase inhibitors demonstrate promise for the treatment of dry eye disease and other ocular inflammatory disorders [PDF]
Doughty, Michael +11 more
core +1 more source
Structure, function and inhibition of poly(ADP-ribose)polymerase, member 14 (PARP14) [PDF]
Levonis, Stephan M +3 more
core +1 more source
Janus Kinase Inhibitors in the Treatment of Crohn’s Disease and Ulcerative Colitis: A Review
Introduction and purpose: Insufficient efficacy and adverse effects of classical therapies for inflammatory bowel disease (IBD), such as ulcerative colitis and Crohn's disease, have prompted the search for new, more targeted treatment methods.
Olimpia Wiciun +7 more
doaj +1 more source
Application of JAK inhibitors in paradoxical reaction through immune-related dermatoses
Biologics play a positive and effective role in the treatment of immune-related dermatoses. However, many other immune-related diseases have also manifested along with biologics treatment.
Yaxin Zhang, Yaxin Zhang, Guan Jiang
doaj +1 more source
Effect of JAK inhibitors on release of CXCL9, CXCL10 and CXCL11 from human airway epithelial cells [PDF]
Barnes, PJ +3 more
core +1 more source

